Cancer Causes & Control

, Volume 17, Issue 7, pp 901–909 | Cite as

Relation of body mass index to cancer risk in 362,552 Swedish men

  • Claudine Samanic
  • Wong-Ho Chow
  • Gloria Gridley
  • Bengt Jarvholm
  • Joseph F. FraumeniJr.
Original Paper

Abstract

Background

Obesity has been linked with increased risk for cancers of the colon, kidney, breast, endometrium and gallbladder. For other cancer sites, the relationship with obesity is less well quantified, and the effect of weight change on cancer risk is unclear.

Methods

We examined the health records of 362,552 Swedish men who underwent at least one physical examination from 1971 to 1992, and were followed until death or the end of 1999. Incident cancer cases were identified by linkage to the Swedish cancer registry. Poisson regression models were used to estimate relative risks of cancer for both body-mass index (BMI) at baseline exam and, in a subgroup of 107,815 men, change in BMI after six years of follow-up, adjusting for age and smoking status.

Results

Compared to men of normal weight, obese men had a significantly increased risk of all cancers combined (RR = 1.1; 95% CI = 1.0–1.2). The risks were most pronounced for esophageal adenocarcinoma (RR = 2.7; 95% CI = 1.3–5.6), renal cell carcinoma (RR = 1.8; 95% CI = 1.4–2.4), malignant melanoma (RR = 1.4; 95% CI = 1.1–1.7), and cancers of the colon (RR = 1.7; 95% CI = 1.5–2.0), rectum (RR = 1.4; 95% CI = 1.1–1.7), and liver (RR = 3.6; 95% CI = 2.6–5.0). Risk of esophageal squamous cell carcinoma was elevated for underweight men whose BMI was less than 18.5 (RR = 3.1; 95% CI = 1.1–8.3). An excess risk for cancers of the pancreas and connective tissue was observed only among nonsmokers. Compared to men whose weight remained stable, men with more than a 15% increase in BMI after six years of follow-up had an elevated risk of pancreas and renal cell cancers.

Conclusions

Obesity and weight gain increase the risk for several forms of cancer in men, and underscore the need for further study into carcinogenic mechanisms and preventive interventions.

Keywords

Obesity Cancer incidence Body mass index Sweden 

References

  1. 1.
    IARC handbooks of cancer prevention (2002) Weight control and physical activity, vol 6. International Agency for Research on Cancer, Lyon, FranceGoogle Scholar
  2. 2.
    Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity and cancer risk. Lancet Oncol 3:565–574PubMedCrossRefGoogle Scholar
  3. 3.
    Wolk A, Gridley G, Svensson M, et al (2001) A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 12:13–21PubMedCrossRefGoogle Scholar
  4. 4.
    Moller H, Mellemgaard A, Lindvig K, Olsen JH (1994) Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 30A:344–350PubMedCrossRefGoogle Scholar
  5. 5.
    Calle E, Rodriguez C, Walker-Thurmond K, Thun MJ. (2003) Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 348:1625–1638PubMedCrossRefGoogle Scholar
  6. 6.
    Samanic C, Gridley G, Chow WH, Lubin J, Hoover RN, Fraumeni JF Jr. (2004) Obesity and cancer risk among white and black United States veterans. Cancer Causes Control 15:35–44PubMedCrossRefGoogle Scholar
  7. 7.
    Bird CL, Frankl HD, Lee ER, Haile RW (1998) Obesity, weight gain, large weight changes, and adenomatous polyps of the left colon and rectum. Am J Epidemiol 147:670–680PubMedGoogle Scholar
  8. 8.
    Isaksson B, Jonsson F, Pedersen NL, Larsson J, Feychting, Permert J (2002) Lifestyle factors and pancreatic risk: a cohort study. Int J Cancer 98:480–482PubMedCrossRefGoogle Scholar
  9. 9.
    Lindblad P, Wolk A, Bergstrom R, Persson I, Adami HO (1994) The role of obesity and weight fluctuations in the etiology of renal cell cancer: a population-based case–control study. Cancer Epidemiol Biomarkers Prev 3:631–639PubMedGoogle Scholar
  10. 10.
    Ballard-Barbash R, Schatzkin A, Taylor PR, Kahle LL (1990) Association of change in body mass with breast cancer. Cancer Res 50:2152–2155PubMedGoogle Scholar
  11. 11.
    Mattsson B, Rutqvist LE, Wallgren A (1985) Undernotification of diagnosed cancer cases to the Stockhom Cancer Registry. Int J Epidemiol 14:64–69PubMedGoogle Scholar
  12. 12.
    Report of a WHO consultation. Obesity: preventing, managing the global epidemic. 894:i–xii, 1–253. 2000. World Health Organization. World Health Organ Tech Rep SerGoogle Scholar
  13. 13.
    Chow WH, Gridley G, Fraumeni JF Jr, Jarvholm B (2000) Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 343:1305–1311PubMedCrossRefGoogle Scholar
  14. 14.
    Preston DL, Lubin JH, Pierce DA, McConney ME (1996) Epicure User's Guide. HiroSoft International Corporation, Seattle, WAGoogle Scholar
  15. 15.
    Breslow NE, Day NE (1987) The design and analysis of cohort studies. In: International Agency for Research on Cancer, ed. In: Statistical methods in cancer research. LyonGoogle Scholar
  16. 16.
    Chow W., Blot W., Vaughan TL, et al (1998) Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 90:150–155PubMedCrossRefGoogle Scholar
  17. 17.
    Wu AH, Wan P, Bernstein L (2001) A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus. Cancer Causes Control 12:721–732PubMedCrossRefGoogle Scholar
  18. 18.
    Lagergren J, Bergstrom R, Nyren O (1999) Association between body mass index and adenocarcinoma of the esophagus and gastric cardia. Arch Intern Med 130:883–890Google Scholar
  19. 19.
    Brown LM, Swanson CA, Gridley G, et al (1995) Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst 87:104–109PubMedGoogle Scholar
  20. 20.
    Lindblad M, Garcia A, Lagergren J (2005) Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nest case–control study. Cancer Causes Control 16:285–294PubMedCrossRefGoogle Scholar
  21. 21.
    Engeland A, Tretli S, Bjorge T (2004) Height and body mass index in relation to esophageal cancer; 23-year follow-up of two million Norwegian mean and women. Cancer Causes Control 15:837–843PubMedCrossRefGoogle Scholar
  22. 22.
    Lagergren J (2005) Adenocarcinoma of the esophagus: what exactly is the size of the problem and who is at risk?. Gut 54(Suppl I):i1–i5PubMedCrossRefGoogle Scholar
  23. 23.
    Brown LM, Hoover RN, Greenberg RS, et al (1994) Are racial differences in squamous cell esophageal cancer explained by alcohol and tobacco use?. J Natl Cancer Inst 86:1340–1345PubMedGoogle Scholar
  24. 24.
    Brown LM, Hoover RN, Silverman D, et al (2001) Excess incidence of squamous cell esophageal cancer among US black men: role of social class and other risk factors. Am J Epidemiol 153:114–122PubMedCrossRefGoogle Scholar
  25. 25.
    Vaughan TL, Davis S, Kristal A, Thomas DB (1995) Obesity, alcohol and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidem Biomarkers Prev 4:85–92Google Scholar
  26. 26.
    Pan SY, Johnson KC, Ugnat AM, Wen SW, Mao Y, Canadian Cancer Registries Epidemiology Research Group (2004) Association of obesity and cancer risk in Canada. Am J Epidemiol 159:259–268PubMedCrossRefGoogle Scholar
  27. 27.
    Russo A, Franceschi S, La Vecchia C, et al (1998) Body size and colorectal-cancer risk. Int J Cancer 78:161–165PubMedCrossRefGoogle Scholar
  28. 28.
    Ford ES (1999) Body mass index and colon cancer in a national sample of adult US men and women. Am J Epidemiol 150:390–398PubMedGoogle Scholar
  29. 29.
    Gerhardsson De Verdier M, Hagman U, Steineck G, Rieger A, Norell SE (1990) Diet, body mass and colorectal cancer: a case-referent study in Stockholm. Int J Cancer 46:832–838PubMedGoogle Scholar
  30. 30.
    Kreger BE, Anderson KM, Shatzkin A, Splansky GL (1992) Serum cholesterol level, body mass index, and the risk of colon cancer. Cancer 70:1038–1043PubMedCrossRefGoogle Scholar
  31. 31.
    Honjo S, Kono S, Shinchi K, et al (1995) The relation of smoking, alcohol use and obesity to risk of sigmoid colon and rectal adenomas. Jpn J Cancer Res 86:1019–1026PubMedGoogle Scholar
  32. 32.
    Le Marchand L, Wilkens LR, Mi MP (1992) Obesity in youth and middle age and risk of colorectal cancer in men. Cancer Causes Control 3:349–354PubMedCrossRefGoogle Scholar
  33. 33.
    Graham S, Marshall J, Haughey B, et al (1988) Dietary epidemiology of cancer of the colon in western New York. Am J Epidemiol 128:490–503PubMedGoogle Scholar
  34. 34.
    Slattery ML, Caan BJ, Benson J, Murtaugh M (2003) Energy balance and rectal cancer: an evaluation of energy intake, energy expenditure, and body mass index. Nutr Cancer 166–171CrossRefGoogle Scholar
  35. 35.
    Mao Y, Pan S, Wen SW, Johnson KC, Canadian Cancer Registries Epidemiology Research Group (2003) Physical inactivity, energy intake, obesity and the risk of rectal cancer in Canada. Int J Cancer 105:831–837PubMedCrossRefGoogle Scholar
  36. 36.
    Giacosa A, Franceschi S, La Vecchia C, Favero A, Andreatta R (1999) Energy intake, overweight, physical exercise and colorectal cancer risk. Eur J Cancer Prev 8:S53–S60PubMedGoogle Scholar
  37. 37.
    Kono S, Handa K, Hayabuchi H, et al (1999) Obesity, weight gain and risk of colon adenomas in Japanese men. Jpn J Cancer Res 90:805–811PubMedGoogle Scholar
  38. 38.
    Bird CL, Frankl HD, Lee ER, Haile RW (1998) Obesity, weight gain, large weight changes, and adenomatous polyps of the left colon and rectum. Am J Epidemiol 147:670–680PubMedGoogle Scholar
  39. 39.
    Whittemore AS, Paffenbarger RS, Anderson K, Lee JE (1985) Early precursors of site-specific cancers in college men and women. J Natl Cancer Inst 74:43–51PubMedGoogle Scholar
  40. 40.
    Shapiro JA, Williams MA, Weiss NS (1999) Body mass index and risk of renal cell carcinoma. Epidemiology 10:188–191PubMedCrossRefGoogle Scholar
  41. 41.
    Moore LE, Wilson RT, Campleman SL (2005) Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk: a review. Cancer Invest 23:240–255PubMedGoogle Scholar
  42. 42.
    Bjorge T, Tretli S, Engeland A (2004) Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol 160:1168–1176PubMedCrossRefGoogle Scholar
  43. 43.
    Presti JC Jr (2005) Obesity and prostate cancer. Curr Opin Urol 15:13–16PubMedCrossRefGoogle Scholar
  44. 44.
    Nomura AM (2001) Body size and prostate cancer risk. Epidemiol Rev 126–131Google Scholar
  45. 45.
    Engeland A, Tretli S, Bjorge T (2003) Height, body mass index, and prostate cancer: a follow-up of 950,000 Norwegian men. Br J Cancer 89:1237–1242PubMedCrossRefGoogle Scholar
  46. 46.
    Andersson SO, Wolk A, Bergstrom R, et al (1997) Body size and prostate cancer: a 20-year follow-up study among 135,006 Swedish construction workers. J Natl Cancer Inst 89:385–389PubMedCrossRefGoogle Scholar
  47. 47.
    Amling CL (2005) Relationship between obesity and prostate cancer. Curr Opin Urol 15:167–171PubMedCrossRefGoogle Scholar
  48. 48.
    Giovanucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC (1997) Height, body weight and risk of prostate cancer. Cancer Epidem Biomarkers Prev 6:557–563Google Scholar
  49. 49.
    Freedland SJ, Giovannucci E, Platz EA (2006) Are findings from studies of obesity and prostate cancer really in conflict?. Cancer Causes and Control 17:5–9PubMedCrossRefGoogle Scholar
  50. 50.
    Larsson SC, Permert J, Hakansson N, Naslund I, Bergkvist L, Wolk A (2005) Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts. Br J Cancer 93:1310–1315PubMedCrossRefGoogle Scholar
  51. 51.
    Silverman DT, Swanson CA, Gloria G, et al (1998) Dietary and nutritional factors and pancreatic cancer: a case–control study based on direct interviews. J Natl Cancer Inst 90:1710–1719PubMedCrossRefGoogle Scholar
  52. 52.
    Patel AV, Rodriguez C, Bernstein L, Chao A, Thun MJ, Calle EE (2005) Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort. Cancer Epidemiol Biomarkers Prev 14:459–466PubMedCrossRefGoogle Scholar
  53. 53.
    Michaud DS, Giovanucci E, Willett WC, Colditz GA, Stampfer MJ, Fuchs CS (2001) Physical activity, obesity, height, and risk or pancreatic cancer. JAMA 286:921–929PubMedCrossRefGoogle Scholar
  54. 54.
    Lee IM, Sesso HD, Oguma Y, Paffenbarger RS (2003) Physical activity, body weight, and pancreatic cancer mortality. Br J Cancer 88:679–683PubMedCrossRefGoogle Scholar
  55. 55.
    Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, Virtamo J, Albanes D (2005) A prospective study of medical conditions, anthropometry, physical activity, and pancreatic cancer in male smokers (Finland). Cancer Causes Control 13:417–426CrossRefGoogle Scholar
  56. 56.
    Howe GR, Jain M, Miller AB (1990) Dietary factors and risk of pancreatic cancer: results of a Canadian population-based case–control study. Int J Cancer 45:604–608PubMedGoogle Scholar
  57. 57.
    Friedman GD, Van Den Eeden SK (1993) Risk factors for pancreatic cancer: an exploratory study. Int J Epidemiol 22:30–37PubMedGoogle Scholar
  58. 58.
    Berrington de Gonzalez A, Sweetland S, Spencer E (2003) A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer 89:519–523PubMedCrossRefGoogle Scholar
  59. 59.
    Qian Y, Fan JG (2005) Obesity, fatty liver and liver cancer. Hepatobiliary Pancreat Dis Int 4:173–177PubMedGoogle Scholar
  60. 60.
    Cladwell SH, Crespo DM, Kang HS, As-Osaimi AMS (2004) Obesity and hepatocellular carcinoma. Gastroenterology 127:S97–S103CrossRefGoogle Scholar
  61. 61.
    Yang SQ, Lin HZ, Hwang J, Chacko VP, Diehl AM (2001) Hepatic hyperplasia and noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition. Cancer Res 61:5016–5023PubMedGoogle Scholar
  62. 62.
    Angelico F, Del Ben M, Conti R, et al (2003) Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases. J Gastroenterol Hepatol 18:588–594PubMedCrossRefGoogle Scholar
  63. 63.
    Pagano G, Pacini G, Gambino R, et al (2002) Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 35:367–372PubMedCrossRefGoogle Scholar
  64. 64.
    Gallus S, Naldi L, Martin L, Martinelli M, Carlo La Vecchia on behalf of the Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology (GISED) (2006) Anthropometric measures and risk of cutaneous malignant melanoma: a case–control study from Italy. Melanoma Res 16:83–87PubMedCrossRefGoogle Scholar
  65. 65.
    Kirkpatrick CS, White E, Lee JA (1994) case–control study of malignant melanoma in Washington State. II. Diet, alcohol, and obesity. Am J Epidemiol 139:869–880PubMedGoogle Scholar
  66. 66.
    Holman CD, Armstrong BK, Heenan PJ (1984) Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors. Br J Cancer 50:673–680PubMedGoogle Scholar
  67. 67.
    Le MG, Cabanes PA, Desvignes V, Chanteau MF, Mlika N, Avril MF (1992) Oral contraceptive use and risk of cutaneous malignant melanoma in a case–control study of French women. Cancer Causes Control 3:199–205PubMedCrossRefGoogle Scholar
  68. 68.
    Gallagher RP, Elwood JM, Hill GB, Coldman AJ, Threlfall WJ, Spinelli JJ (1985) Reproductive factors, oral contraceptives and risk of malignant melanoma in women: Western Canada Melanoma Study. Br J Cancer 52:901–907PubMedGoogle Scholar
  69. 69.
    Osterlind A, Tucker MA, Stone BJ, Jensen OM (1988) The Danish case–control study of cutaneous malignant melanoma. Int J Cancer 42:821–824PubMedGoogle Scholar
  70. 70.
    Shors AR, Solomon C, McTiernan A, White E (2001) Melanoma risk in relation to height, weight and exercise (United States). Cancer Causes Control 12:599–606PubMedCrossRefGoogle Scholar
  71. 71.
    Thune I, Olsen A, Albrektsen G, Tretli S (1993) Cutaneous malignant melanoma: association with height, weight and body-surface area. A prospective study in Norway. Int J Cancer 55:555–561PubMedGoogle Scholar
  72. 72.
    Millen AE, Tucker MA, Hartge P, et al (2004) Diet and melanoma in a case–control study. Cancer Epidemiol Biomarkers Prev 13:1042–1051PubMedGoogle Scholar
  73. 73.
    Osterlind A, Tucker MA, Stone BJ, Jensen OM (1988) The Danish case–control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women. Int J Cancer 42:821–824PubMedGoogle Scholar
  74. 74.
    Veierod MB, Thelle DS, Laake P (1997) Diet and risk of cutaneous malignant melanoma: a prospective study of 50,757 Norwegian men and women. Int J Cancer 71:600–604PubMedCrossRefGoogle Scholar
  75. 75.
    Snell RS, Bischitz PG (1960) The effect of large doses of estrogen and progesterone on melanin pigmentation. J Invest Dermatol 35:75–82CrossRefGoogle Scholar
  76. 76.
    Armstrong BK, Englund A (1996) Cutaneous malignant melanoma. In: Schottenfield D, Fraumeni JF Jr. (eds) New York, NY: Oxford University Press, pp 1282–1312Google Scholar
  77. 77.
    Beral V, Evans S, Shaw H (1984) Oral contraceptive use and malignant melanoma in Australia. Br J Cancer 50:681–685PubMedGoogle Scholar
  78. 78.
    Feskanich D, Hunter DJ, Willett WC, et al (1999) Oral contraceptive use and risk of melanoma in premenopausal women. Br J Cancer 81:918–923PubMedCrossRefGoogle Scholar
  79. 79.
    Holly EA, Cress RD, Ahn DK (1995) Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive use. Am J Epidemiol 141:943–950PubMedGoogle Scholar
  80. 80.
    Karagas MR, Stukel TA, Dykes J, et al (2002) A pooled analysis of 10 case–control studies of melanoma and oral contraceptive use. Br J Cancer 86:1085–1092PubMedCrossRefGoogle Scholar
  81. 81.
    Tavani S, Soler M, La Vecchia C, Negri E, Gallus S, Franceschi S (1999) Body weight and risk of soft-tissue sarcoma. Br J Cancer 81:890–892PubMedCrossRefGoogle Scholar
  82. 82.
    Cerhan JR, Janney CA, Vachon CM, et al (2002) Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study. Am J Epidemiol 156:527–535PubMedCrossRefGoogle Scholar
  83. 83.
    Holly EA, Lele C, Bracci PM, McGrath MS (1999) case–control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol 150:375–389PubMedGoogle Scholar
  84. 84.
    Estey E, Thall P, Kantarjian H, Pierce S, Kornblau S, Keating M (1997) Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia. Leukemia 11:1661–1664PubMedCrossRefGoogle Scholar
  85. 85.
    Sobal J, Stunkard AJ (1989) Socioeconomic status and obesity: a review of the literature. Psychol Bull 105:260–275PubMedCrossRefGoogle Scholar
  86. 86.
    Oliveria SA, Christos PJ (1997) The epidemiology of physical activity and cancer. Ann NY Acad Sci 29:79–90Google Scholar
  87. 87.
    Tymchuk CN, Tessler SB, Aronson WJ, Barnard WJ (1998) Effects of diet and exercise on insulin, sex-hormone binding globulin, and prostate-specific antigen. Nutr Cancer 31:127–131PubMedCrossRefGoogle Scholar
  88. 88.
    Key TJ, Allen NE, Spencer EA, Travis RC (2002) The effect of diet on risk of cancer. Lancet 360:861–888PubMedCrossRefGoogle Scholar
  89. 89.
    La Vecchia C (1994) Dietary fat, obesity and cancer. In: Hill M, Giacosa A, Caygill C (eds) Epidemiology of diet and cancer. Ellis Horwood Limited, New York, pp 277–291Google Scholar
  90. 90.
    Molarius A, Seidell JC, Kuulasmaa K, Dobson AJ, Sans S (1997) Smoking and relative body weight: an international perspective from the WHO MONICA project. J Epidemiol Community Health 51:252–560PubMedCrossRefGoogle Scholar
  91. 91.
    Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Rev 4:579–591CrossRefGoogle Scholar
  92. 92.
    Giovanucci E (1999) Insulin-like growth factor-1 and binding protein-3 and risk of cancer. Horm Res 51:34–41CrossRefGoogle Scholar
  93. 93.
    Kahn BB, Flier JS (2000) Obesity and insulin resistance. J Clin Invest 106:473–481PubMedCrossRefGoogle Scholar
  94. 94.
    Marchav S (1998) The haematopoietic effects of growth hormone and insulin-like growth factor-I. J Ped Endocrinol Metab 11:677–685Google Scholar
  95. 95.
    Cottam DR, Mattar SG, Barinas-Mitchell E, et al (2004) The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obesity Surgery 14:589–600PubMedCrossRefGoogle Scholar
  96. 96.
    Shacter E, Weitzman SA (2002) Chronic inflammation and cancer. Oncology 16:217–229PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2006

Authors and Affiliations

  • Claudine Samanic
    • 1
  • Wong-Ho Chow
    • 1
  • Gloria Gridley
    • 1
  • Bengt Jarvholm
    • 2
  • Joseph F. FraumeniJr.
    • 1
  1. 1.Department of Health and Human Services, Division of Cancer Epidemiology and GeneticsNational Cancer Institute, National Institutes of HealthBethesdaUSA
  2. 2.Department of Public Health and Clinical MedicineUmea UniversityUmeaSweden

Personalised recommendations